PERCUTANEOUS CORONARY INTERVENTION side effect
What is PERCUTANEOUS CORONARY INTERVENTION ?PERCUTANEOUS CORONARY INTERVENTION : Atacand Side Effects Report #5419183-X
Physician from UNITED STATES reported ATACAND problem on Aug 15, 2007. Male patient, 72 years of age, weighting 164.0 lb, was treated with ATACAND. After drug was administered, patient experienced the following problems/side effects: angina unstable, percutaneous coronary intervention, . ATACAND dosage: 32MG ONCE DAILY PO. During the same period patient was treated with ALLOPURINOL, PLAVIX, SIMVASTATIN, ASPIRIN, FELODIPINE, HYDROCHLOROTHIAZIDE, GLYBURIDE, AVANDIA. Patient was hospitalized. Patient recovered.
PERCUTANEOUS CORONARY INTERVENTION : Telmisartan Side Effects Report #5547626-X
TELMISARTAN problem was reported by a Consumer or non-health professional from on Dec 04, 2007. Female patient was diagnosed with hypertension and was treated with TELMISARTAN. After drug was administered, patient experienced the following problems/side effects: coronary revascularisation, myocardial infarction, percutaneous coronary intervention, . TELMISARTAN dosage: INITIAL DOSE 40 MG, DOSE DOUBLED DEPENDING ON BLOOD PRESSURE AND DIABETIC STATUS. During the same period patient was treated with ASPIRIN, CLOPIDOGREL, ATORVASTATIN, SIROLIMUS. Patient recovered.
PERCUTANEOUS CORONARY INTERVENTION : Lotensin Side Effects Report #5479156-8
Physician from UNITED STATES reported LOTENSIN problem on Oct 01, 2007. Male patient, 65 years of age, weighting 218.0 lb, was diagnosed with hypertension, coronary artery disease and was treated with LOTENSIN. After drug was administered, patient experienced the following problems/side effects: coronary artery disease, myocardial infarction, percutaneous coronary intervention, pharyngeal oedema, stent placement, tongue oedema, . LOTENSIN dosage: 40 MG, BID. During the same period patient was treated with BENAZEPRIL HYDROCHLORIDE, GLUCOVANCE, BYETTA, ACTOS, LEVEMIR, VALIUM, PLAVIX, LIPITOR. Patient recovered.
PERCUTANEOUS CORONARY INTERVENTION : Ritonavir Side Effects Report #5384137-9
RITONAVIR SOFT GELATIN CAPSULES problem was reported by a Consumer or non-health professional from IRELAND on July 03, 2007. Male patient, weighting 200.6 lb, was diagnosed with hiv infection, cardiovascular event prophylaxis, intermittent claudication, arterial stenosis and was treated with RITONAVIR SOFT GELATIN CAPSULES. After drug was administered, patient experienced the following problems/side effects: arterial stenosis, intermittent claudication, percutaneous coronary intervention, . RITONAVIR SOFT GELATIN CAPSULES dosage: unknown. During the same period patient was treated with ZIDOVUDINE, TENOFOVIR, ABACAVIR, LISINOPRIL, ASPIRIN. Patient was hospitalized. Patient recovered.
PERCUTANEOUS CORONARY INTERVENTION : Ritonavir Side Effects Report #5384137-9
Consumer or non-health professional from IRELAND reported RITONAVIR SOFT GELATIN CAPSULES problem on July 03, 2007. Male patient, weighting 200.6 lb, was diagnosed with hiv infection, cardiovascular event prophylaxis, intermittent claudication, arterial stenosis and was treated with RITONAVIR SOFT GELATIN CAPSULES. After drug was administered, patient experienced the following problems/side effects: arterial stenosis, intermittent claudication, percutaneous coronary intervention, . RITONAVIR SOFT GELATIN CAPSULES dosage: unknown. During the same period patient was treated with ZIDOVUDINE, TENOFOVIR, ABACAVIR, LISINOPRIL, ASPIRIN. Patient was hospitalized. Patient recovered.